Clinical trial
Radioimmunotherapy With 90Y Zevalin for Orbital Lymphoma
NCT00387023 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00387023 |
|---|---|
| Title | Radioimmunotherapy With 90Y Zevalin for Orbital Lymphoma |
| Official title | Pilot Trial of Radioimmunotherapy With Yttrium 90-Labeled (90Y) Zevalin for Low-Grade Follicular Non-Hodgkin's Lymphoma or MALT of the Orbit/Conjunctiva |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | Biogen Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Non-Hodgkin's Lymphoma, Lymphoma |
| Intervention type | Drug |
| Interventions | Rituximab, Zevalin |
| Enrollment | 12 |
| Start date | Feb 1, 2004 |
| Primary completion | Jul 1, 2012 |
| Completion | Jul 1, 2012 |
| First posted | Oct 12, 2006 |
| Last update posted | Nov 18, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: